{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:40:13Z","timestamp":1794958813118,"version":"4.9.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>While aging is the main risk factor for Alzheimer\u00b4s disease (AD), emerging evidence suggests that metabolic alterations such as type 2 diabetes (T2D) are also major contributors. Indeed, several studies have described a close relationship between AD and T2D with clinical evidence showing that both diseases coexist. A hallmark pathological event in AD is amyloid-\u03b2 (A\u03b2) deposition in the brain as either amyloid plaques or around leptomeningeal and cortical arterioles, thus constituting cerebral amyloid angiopathy (CAA). CAA is observed in 85\u201395% of autopsy cases with AD and it contributes to AD pathology by limiting perivascular drainage of A\u03b2.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To further explore these alterations when AD and T2D coexist, we have used in vivo multiphoton microscopy to analyze over time the A\u03b2 deposition in the form of plaques and CAA in a relevant model of AD (APPswe\/PS1dE9) combined with T2D (db\/db). We have simultaneously assessed the effects of high-fat diet-induced prediabetes in AD mice. Since both plaques and CAA are implicated in oxidative-stress mediated vascular damage in the brain, as well as in the activation of matrix metalloproteinases (MMP), we have also analyzed oxidative stress by Amplex Red oxidation, MMP activity by DQ<jats:sup>\u2122<\/jats:sup> Gelatin, and vascular functionality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that prediabetes accelerates amyloid plaque and CAA deposition, suggesting that initial metabolic alterations may directly affect AD pathology. T2D significantly affects vascular pathology and CAA deposition, which is increased in AD-T2D mice, suggesting that T2D favors vascular accumulation of A\u03b2. Moreover, T2D synergistically contributes to increase CAA mediated oxidative stress and MMP activation, affecting red blood cell velocity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data support the cross-talk between metabolic disease and A\u03b2 deposition that affects vascular integrity, ultimately contributing to AD pathology and related functional changes in the brain microvasculature.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12987-022-00380-6","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T05:02:47Z","timestamp":1667797367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer\u00b4s disease and type two diabetes"],"prefix":"10.1186","volume":"19","author":[{"given":"Maria","family":"Vargas-Soria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jose","family":"Ramos-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"del Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Hierro-Bujalance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Carranza-Naval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Calvo-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne J.","family":"van Veluw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan W.","family":"Stitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Sim\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Bacskai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Infante-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Garcia-Alloza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"issue":"4","key":"380_CR1","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","volume":"82","author":"TL Spires-Jones","year":"2014","unstructured":"Spires-Jones TL, Hyman BT. The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease. Neuron. 2014;82(4):756\u201371.","journal-title":"Neuron"},{"issue":"1","key":"380_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease\u2014one peptide, two pathways. Nat Rev Neurol. 2020;16(1):30\u201342.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"380_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.brainresrev.2003.08.001","volume":"43","author":"AA Rensink","year":"2003","unstructured":"Rensink AA, de Waal RM, Kremer B, Verbeek MM. Pathogenesis of cerebral amyloid angiopathy. Brain Res Brain Res Rev. 2003;43(2):207\u201323.","journal-title":"Brain Res Brain Res Rev"},{"issue":"1","key":"380_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5853\/jos.2015.17.1.17","volume":"17","author":"M Yamada","year":"2015","unstructured":"Yamada M. Cerebral amyloid angiopathy: emerging concepts. J Stroke. 2015;17(1):17\u201330.","journal-title":"J Stroke"},{"issue":"1","key":"380_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/alz.12366","volume":"18","author":"L Jakel","year":"2022","unstructured":"Jakel L, De Kort AM, Klijn CJM, Schreuder F, Verbeek MM. Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis. Alzheimers Dement. 2022;18(1):10\u201328. https:\/\/doi.org\/10.1002\/alz.12366","journal-title":"Alzheimers Dement"},{"issue":"6","key":"380_CR6","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1111\/j.1471-4159.2009.06096.x","volume":"109","author":"M Garcia-Alloza","year":"2009","unstructured":"Garcia-Alloza M, Prada C, Lattarulo C, Fine S, Borrelli LA, Betensky R, et al. Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice. J Neurochem. 2009;109(6):1636\u201347.","journal-title":"J Neurochem"},{"key":"380_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav9518","author":"R Nortley","year":"2019","unstructured":"Nortley R, Korte N, Izquierdo P, Hirunpattarasilp C, Mishra A, Jaunmuktane Z, et al. Amyloid beta oligomers constrict human capillaries in Alzheimer\u2019s disease via signaling to pericytes. Science. 2019. https:\/\/doi.org\/10.1126\/science.aav9518.","journal-title":"Science"},{"issue":"8","key":"380_CR8","doi-asserted-by":"publisher","first-page":"E881","DOI":"10.1073\/pnas.1414930112","volume":"112","author":"BH Han","year":"2015","unstructured":"Han BH, Zhou ML, Johnson AW, Singh I, Liao F, Vellimana AK, et al. Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice. Proc Natl Acad Sci U S A. 2015;112(8):E881\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"380_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2020.104931","author":"Y Liu","year":"2020","unstructured":"Liu Y, Chen Z, Li B, Yao H, Zarka M, Welch J, et al. Supplementation with gamma-glutamylcysteine (gamma-GC) lessens oxidative stress, brain inflammation and amyloid pathology and improves spatial memory in a murine model of AD. Neurochem Int. 2020. https:\/\/doi.org\/10.1016\/j.neuint.2020.104931.","journal-title":"Neurochem Int"},{"key":"380_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.neubiorev.2016.03.005","volume":"64","author":"D Baglietto-Vargas","year":"2016","unstructured":"Baglietto-Vargas D, Shi J, Yaeger DM, Ager R, LaFerla FM. Diabetes and Alzheimer\u2019s disease crosstalk. Neurosci Biobehav Rev. 2016;64:272\u201387.","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"380_CR11","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.2337\/db13-1954","volume":"63","author":"FG De Felice","year":"2014","unstructured":"De Felice FG, Ferreira ST. Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes. 2014;63(7):2262\u201372.","journal-title":"Diabetes"},{"key":"380_CR12","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2019","unstructured":"International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels; 2019. https:\/\/www.diabetesatlas.org.","edition":"9"},{"issue":"15","key":"380_CR13","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1073\/pnas.1000645107","volume":"107","author":"S Takeda","year":"2010","unstructured":"Takeda S, Sato N, Uchio-Yamada K, Sawada K, Kunieda T, Takeuchi D, et al. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci U S A. 2010;107(15):7036\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"380_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.psyneuen.2015.12.001","volume":"65","author":"C Infante-Garcia","year":"2016","unstructured":"Infante-Garcia C, Ramos-Rodriguez JJ, Galindo-Gonzalez L, Garcia-Alloza M. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer\u2019s disease and type 2 diabetes. Psychoneuroendocrinology. 2016;65:15\u201325.","journal-title":"Psychoneuroendocrinology"},{"key":"380_CR15","doi-asserted-by":"publisher","first-page":"239821282096172","DOI":"10.1177\/2398212820961725","volume":"4","author":"GE Ennis","year":"2020","unstructured":"Ennis GE, Saelzler U, Umpierrez GE, Moffat SD. Prediabetes and working memory in older adults. Brain Neurosci Adv. 2020;4:2398212820961725.","journal-title":"Brain Neurosci Adv"},{"key":"380_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.psyneuen.2014.06.005","volume":"48","author":"JJ Ramos-Rodriguez","year":"2014","unstructured":"Ramos-Rodriguez JJ, Ortiz-Barajas O, Gamero-Carrasco C, de la Rosa PR, Infante-Garcia C, Zopeque-Garcia N, et al. Prediabetes-induced vascular alterations exacerbate central pathology in APPswe\/PS1dE9 mice. Psychoneuroendocrinology. 2014;48:123\u201335.","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"380_CR17","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.neurobiolaging.2003.09.008","volume":"25","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, Slunt HH, Gonzales V, Jenkins NA, Copeland NG, Borchelt DR. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol Aging. 2004;25(7):885\u201392.","journal-title":"Neurobiol Aging"},{"issue":"3740","key":"380_CR18","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1126\/science.153.3740.1127","volume":"153","author":"KP Hummel","year":"1966","unstructured":"Hummel KP, Dickie MM, Coleman DL. Diabetes, a new mutation in the mouse. Science. 1966;153(3740):1127\u20138.","journal-title":"Science"},{"key":"380_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.psyneuen.2015.07.606","volume":"62","author":"JJ Ramos-Rodriguez","year":"2015","unstructured":"Ramos-Rodriguez JJ, Jimenez-Palomares M, Murillo-Carretero MI, Infante-Garcia C, Berrocoso E, Hernandez-Pacho F, et al. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer\u2019s disease. Psychoneuroendocrinology. 2015;62:69\u201379.","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"380_CR20","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","volume":"24","author":"M Garcia-Alloza","year":"2006","unstructured":"Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, et al. Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis. 2006;24(3):516\u201324.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"380_CR21","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1007\/s12035-016-0015-z","volume":"54","author":"C Infante-Garcia","year":"2017","unstructured":"Infante-Garcia C, Jose Ramos-Rodriguez J, Delgado-Olmos I, Gamero-Carrasco C, Teresa Fernandez-Ponce M, Casas L, et al. Long-term mangiferin extract treatment improves central pathology and cognitive deficits in APP\/PS1 mice. Mol Neurobiol. 2017;54(6):4696\u2013704.","journal-title":"Mol Neurobiol"},{"issue":"9","key":"380_CR22","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00424-016-1832-7","volume":"468","author":"IM Schiessl","year":"2016","unstructured":"Schiessl IM, Castrop H. Deep insights: intravital imaging with two-photon microscopy. Pflugers Arch. 2016;468(9):1505\u201316.","journal-title":"Pflugers Arch"},{"issue":"7","key":"380_CR23","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/jcbfm.2011.196","volume":"32","author":"AY Shih","year":"2012","unstructured":"Shih AY, Driscoll JD, Drew PJ, Nishimura N, Schaffer CB, Kleinfeld D. Two-photon microscopy as a tool to study blood flow and neurovascular coupling in the rodent brain. J Cereb Blood Flow Metab. 2012;32(7):1277\u2013309.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"46","key":"380_CR24","doi-asserted-by":"publisher","first-page":"18190","DOI":"10.1523\/JNEUROSCI.1592-13.2013","volume":"33","author":"JJ Iliff","year":"2013","unstructured":"Iliff JJ, Wang M, Zeppenfeld DM, Venkataraman A, Plog BA, Liao Y, et al. Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J Neurosci. 2013;33(46):18190\u20139.","journal-title":"J Neurosci"},{"issue":"2","key":"380_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1523\/JNEUROSCI.3854-05.2006","volume":"26","author":"EM Robbins","year":"2006","unstructured":"Robbins EM, Betensky RA, Domnitz SB, Purcell SM, Garcia-Alloza M, Greenberg C, et al. Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. J Neurosci. 2006;26(2):365\u201371.","journal-title":"J Neurosci"},{"issue":"3","key":"380_CR26","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","volume":"24","author":"M Garcia-Alloza","year":"2006","unstructured":"Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, et al. Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis. 2006;24(3):516\u201324.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"380_CR27","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1523\/JNEUROSCI.23-06-02212.2003","volume":"23","author":"ME McLellan","year":"2003","unstructured":"McLellan ME, Kajdasz ST, Hyman BT, Bacskai BJ. In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy. J Neurosci. 2003;23(6):2212\u20137.","journal-title":"J Neurosci"},{"issue":"7179","key":"380_CR28","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nature06616","volume":"451","author":"M Meyer-Luehmann","year":"2008","unstructured":"Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, Rozkalne A, et al. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer\u2019s disease. Nature. 2008;451(7179):720\u20134.","journal-title":"Nature"},{"issue":"11","key":"380_CR29","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1097\/01.jnen.0000240468.12543.af","volume":"65","author":"M Garcia-Alloza","year":"2006","unstructured":"Garcia-Alloza M, Dodwell SA, Meyer-Luehmann M, Hyman BT, Bacskai BJ. Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. J Neuropathol Exp Neurol. 2006;65(11):1082\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"key":"380_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00592-020-01648-9","volume":"58","author":"Y You","year":"2021","unstructured":"You Y, Liu Z, Chen Y, Xu Y, Qin J, Guo S, et al. The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis.\u00a0Acta Diabetol. 2021;58:671\u201385. https:\/\/doi.org\/10.1007\/s00592-020-01648-9.","journal-title":"Acta Diabetol"},{"issue":"10","key":"380_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/brainsci9100262","volume":"9","author":"MR Hayden","year":"2019","unstructured":"Hayden MR. Type 2 diabetes mellitus increases the risk of late-onset Alzheimer\u2019s disease: ultrastructural remodeling of the neurovascular unit and diabetic gliopathy. Brain Sci. 2019;9(10):262.","journal-title":"Brain Sci"},{"key":"380_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/epirev\/mxs012","volume":"35","author":"NT Vagelatos","year":"2013","unstructured":"Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor for Alzheimer\u2019s disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev. 2013;35:152\u201360.","journal-title":"Epidemiol Rev"},{"key":"380_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fnagi.2019.00088","volume":"11","author":"C Holscher","year":"2019","unstructured":"Holscher C. Insulin signaling impairment in the brain as a risk factor in Alzheimer\u2019s Disease. Front Aging Neurosci. 2019;11:88.","journal-title":"Front Aging Neurosci"},{"key":"380_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/2051-5960-2-64","volume":"2","author":"DM Niedowicz","year":"2014","unstructured":"Niedowicz DM, Reeves VL, Platt TL, Kohler K, Beckett TL, Powell DK, et al. Obesity and diabetes cause cognitive dysfunction in the absence of accelerated beta-amyloid deposition in a novel murine model of mixed or vascular dementia. Acta Neuropathol Commun. 2014;2:64.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"380_CR35","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.18632\/aging.202262","volume":"13","author":"Y Guo","year":"2020","unstructured":"Guo Y, Ma X, Li P, Dong S, Huang X, Ren X, et al. High-fat diet induced discrepant peripheral and central nervous systems insulin resistance in APPswe\/PS1dE9 and wild-type C57BL\/6J mice. Aging (Albany NY). 2020;13(1):1236\u201350.","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"380_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuron.2005.06.030","volume":"47","author":"E McGowan","year":"2005","unstructured":"McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, et al. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2005;47(2):191\u20139.","journal-title":"Neuron"},{"key":"380_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-3-319-18365-7_4","volume":"863","author":"M Yamada","year":"2015","unstructured":"Yamada M, Ono K, Hamaguchi T, Noguchi-Shinohara M. Natural phenolic compounds as therapeutic and preventive agents for cerebral amyloidosis. Adv Exp Med Biol. 2015;863:79\u201394.","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"380_CR38","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1007\/s12035-019-01678-7","volume":"56","author":"Y Inoue","year":"2019","unstructured":"Inoue Y, Ueda M, Masuda T, Misumi Y, Yamashita T, Ando Y. Memantine, a noncompetitive N-Methyl-D-Aspartate receptor antagonist, attenuates cerebral amyloid angiopathy by increasing insulin-degrading enzyme expression. Mol Neurobiol. 2019;56(12):8573\u201388.","journal-title":"Mol Neurobiol"},{"key":"380_CR39","first-page":"107385842095481","volume":"27","author":"M Gireud-Goss","year":"2020","unstructured":"Gireud-Goss M, Mack AF, McCullough LD, Urayama A. Cerebral amyloid angiopathy and blood-brain barrier dysfunction. Neuroscientist. 2020;27:1073858420954811.","journal-title":"Neuroscientist"},{"key":"380_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neurobiolaging.2018.06.004","volume":"70","author":"S Magaki","year":"2018","unstructured":"Magaki S, Tang Z, Tung S, Williams CK, Lo D, Yong WH, et al. The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier. Neurobiol Aging. 2018;70:70\u20137.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"380_CR41","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/01.jnen.0000171644.00180.fc","volume":"64","author":"SB Domnitz","year":"2005","unstructured":"Domnitz SB, Robbins EM, Hoang AW, Garcia-Alloza M, Hyman BT, Rebeck GW, et al. Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease. J Neuropathol Exp Neurol. 2005;64(7):588\u201394.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"380_CR42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11(8):457\u201370.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"380_CR43","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1038\/s41598-018-21641-1","volume":"8","author":"G Di Fede","year":"2018","unstructured":"Di Fede G, Catania M, Maderna E, Ghidoni R, Benussi L, Tonoli E, et al. Molecular subtypes of Alzheimer\u2019s disease. Sci Rep. 2018;8(1):3269.","journal-title":"Sci Rep"},{"issue":"10","key":"380_CR44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591\u2013604.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"380_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-020-00972-z","volume":"8","author":"L Jakel","year":"2020","unstructured":"Jakel L, Kuiperij HB, Gerding LP, Custers EEM, van den Berg E, Jolink WMT, et al. Disturbed balance in the expression of MMP9 and TIMP3 in cerebral amyloid angiopathy-related intracerebral haemorrhage. Acta Neuropathol Commun. 2020;8(1):99.","journal-title":"Acta Neuropathol Commun"},{"issue":"1\u20134","key":"380_CR46","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000334916","volume":"10","author":"A Carrano","year":"2012","unstructured":"Carrano A, Hoozemans JJ, van der Vies SM, van Horssen J, de Vries HE, Rozemuller AJ. Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy. Neurodegener Dis. 2012;10(1\u20134):329\u201331.","journal-title":"Neurodegener Dis"},{"issue":"9","key":"380_CR47","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3390\/ijms18091965","volume":"18","author":"Y Yamazaki","year":"2017","unstructured":"Yamazaki Y, Kanekiyo T. Blood-brain barrier dysfunction and the pathogenesis of Alzheimer\u2019s disease. Int J Mol Sci. 2017;18(9):1965.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"380_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3233\/JAD-122254","volume":"35","author":"NK Acharya","year":"2013","unstructured":"Acharya NK, Levin EC, Clifford PM, Han M, Tourtellotte R, Chamberlain D, et al. Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladib. J Alzheimers Dis. 2013;35(1):179\u201398.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"380_CR49","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s40478-020-01042-0","volume":"8","author":"SH Kim","year":"2020","unstructured":"Kim SH, Ahn JH, Yang H, Lee P, Koh GY, Jeong Y. Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer\u2019s disease mouse model. Acta Neuropathol Commun. 2020;8(1):181.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"380_CR50","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ana.24271","volume":"76","author":"BT Kress","year":"2014","unstructured":"Kress BT, Iliff JJ, Xia M, Wang M, Wei HS, Zeppenfeld D, et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol. 2014;76(6):845\u201361.","journal-title":"Ann Neurol"},{"issue":"1","key":"380_CR51","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1038\/s41467-018-07318-3","volume":"9","author":"H Mestre","year":"2018","unstructured":"Mestre H, Tithof J, Du T, Song W, Peng W, Sweeney AM, et al. Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension. Nat Commun. 2018;9(1):4878.","journal-title":"Nat Commun"},{"issue":"1","key":"380_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JAD-142976","volume":"46","author":"LY Di Marco","year":"2015","unstructured":"Di Marco LY, Farkas E, Martin C, Venneri A, Frangi AF. Is Vasomotion in cerebral arteries impaired in Alzheimer\u2019s disease? J Alzheimers Dis. 2015;46(1):35\u201353.","journal-title":"J Alzheimers Dis"},{"key":"380_CR53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fnagi.2014.00251","volume":"6","author":"AW Morris","year":"2014","unstructured":"Morris AW, Carare RO, Schreiber S, Hawkes CA. The cerebrovascular basement membrane: role in the clearance of beta-amyloid and cerebral amyloid angiopathy. Front Aging Neurosci. 2014;6:251.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"380_CR54","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4093\/dmj.2021.0146","volume":"46","author":"X Li","year":"2022","unstructured":"Li X, Cai Y, Zhang Z, Zhou J. Glial and vascular cell regulation of the blood-brain barrier in diabetes. Diabetes Metab J. 2022;46(2):222\u201338.","journal-title":"Diabetes Metab J"},{"issue":"3","key":"380_CR55","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.neuron.2019.10.033","volume":"105","author":"SJ van Veluw","year":"2020","unstructured":"van Veluw SJ, Hou SS, Calvo-Rodriguez M, Arbel-Ornath M, Snyder AC, Frosch MP, et al. Vasomotion as a driving force for paravascular clearance in the awake mouse brain. Neuron. 2020;105(3):549\u201361.","journal-title":"Neuron"},{"issue":"10","key":"380_CR56","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/jcbfm.2008.62","volume":"28","author":"MM Poels","year":"2008","unstructured":"Poels MM, Ikram MA, Vernooij MW, Krestin GP, Hofman A, Niessen WJ, et al. Total cerebral blood flow in relation to cognitive function: the Rotterdam Scan Study. J Cereb Blood Flow Metab. 2008;28(10):1652\u20135.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Pt 9","key":"380_CR57","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1093\/brain\/awm156","volume":"130","author":"HK Shin","year":"2007","unstructured":"Shin HK, Jones PB, Garcia-Alloza M, Borrelli L, Greenberg SM, Bacskai BJ, et al. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain. 2007;130(Pt 9):2310\u20139.","journal-title":"Brain"},{"issue":"5","key":"380_CR58","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbadis.2015.08.024","volume":"1862","author":"A Keable","year":"2016","unstructured":"Keable A, Fenna K, Yuen HM, Johnston DA, Smyth NR, Smith C, et al. Deposition of amyloid beta in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy. Biochim Biophys Acta. 2016;1862(5):1037\u201346.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"380_CR59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/WAD.0000000000000280","volume":"33","author":"R Squitti","year":"2019","unstructured":"Squitti R, Mendez A, Ricordi C, Siotto M, Goldberg R. Copper in glucose intolerance, cognitive decline, and Alzheimer disease. Alzheimer Dis Assoc Disord. 2019;33(1):77\u201385.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"9","key":"380_CR60","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1177\/0271678X16655551","volume":"36","author":"RG Rempe","year":"2016","unstructured":"Rempe RG, Hartz AMS, Bauer B. Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers. J Cereb Blood Flow Metab. 2016;36(9):1481\u2013507.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"22","key":"380_CR61","doi-asserted-by":"publisher","first-page":"11751","DOI":"10.1074\/jbc.M115.708438","volume":"291","author":"E Ugarte-Berzal","year":"2016","unstructured":"Ugarte-Berzal E, Vandooren J, Bailon E, Opdenakker G, Garcia-Pardo A. Inhibition of MMP-9-dependent degradation of gelatin, but not other MMP-9 substrates, by the MMP-9 Hemopexin domain blades 1 and 4. J Biol Chem. 2016;291(22):11751\u201360.","journal-title":"J Biol Chem"},{"key":"380_CR62","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fnins.2018.00930","volume":"12","author":"P Van Dyken","year":"2018","unstructured":"Van Dyken P, Lacoste B. Impact of metabolic syndrome on neuroinflammation and the blood-brain barrier. Front Neurosci. 2018;12:930.","journal-title":"Front Neurosci"},{"key":"380_CR63","doi-asserted-by":"publisher","first-page":"104818","DOI":"10.1016\/j.neuint.2020.104818","volume":"140","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Liu H, Chen Z, Yu M, Li J, Dong H, et al. TLR4-mediated hippocampal MMP\/TIMP imbalance contributes to the aggravation of perioperative neurocognitive disorder in db\/db mice. Neurochem Int. 2020;140:104818.","journal-title":"Neurochem Int"},{"issue":"1","key":"380_CR64","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/0271678X19899377","volume":"41","author":"SJ van Veluw","year":"2021","unstructured":"van Veluw SJ, Frosch MP, Scherlek AA, Lee D, Greenberg SM, Bacskai BJ. In vivo characterization of spontaneous microhemorrhage formation in mice with cerebral amyloid angiopathy. J Cereb Blood Flow Metab. 2021;41(1):82\u201391.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"380_CR65","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/ana.25512","volume":"86","author":"SJ van Veluw","year":"2019","unstructured":"van Veluw SJ, Scherlek AA, Freeze WM, Ter Telgte A, van der Kouwe AJ, Bacskai BJ, et al. Different microvascular alterations underlie microbleeds and microinfarcts. Ann Neurol. 2019;86(2):279\u201392.","journal-title":"Ann Neurol"},{"key":"380_CR66","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3389\/fphys.2018.00806","volume":"9","author":"C Carvalho","year":"2018","unstructured":"Carvalho C, Moreira PI. Oxidative stress: a major player in cerebrovascular alterations associated to neurodegenerative events. Front Physiol. 2018;9:806.","journal-title":"Front Physiol"},{"issue":"3","key":"380_CR67","doi-asserted-by":"publisher","first-page":"H647","DOI":"10.1152\/ajpheart.01271.2010","volume":"301","author":"NS Zinkevich","year":"2011","unstructured":"Zinkevich NS, Gutterman DD. ROS-induced ROS release in vascular biology: redox-redox signaling. Am J Physiol Heart Circ Physiol. 2011;301(3):H647\u201353.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"380_CR68","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/biomedicines10051009","volume":"10","author":"R Moretti","year":"2022","unstructured":"Moretti R, Janjusevic M, Fluca AL, Saro R, Gagno G, Pierri A, et al. Common shared pathogenic aspects of small vessels in heart and brain disease. Biomedicines. 2022;10(5):1009.","journal-title":"Biomedicines"},{"issue":"1","key":"380_CR69","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12868-017-0384-x","volume":"18","author":"N Obadia","year":"2017","unstructured":"Obadia N, Lessa MA, Daliry A, Silvares RR, Gomes F, Tibirica E, et al. Cerebral microvascular dysfunction in metabolic syndrome is exacerbated by ischemia-reperfusion injury. BMC Neurosci. 2017;18(1):67.","journal-title":"BMC Neurosci"},{"key":"380_CR70","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-020-01648-9","author":"X Zhou","year":"2019","unstructured":"Zhou X, Qian Y, Yuan D, Feng Q, He P. H(2) O(2) -induced microvessel barrier dysfunction: the interplay between reactive oxygen species, nitric oxide, and peroxynitrite. Physiol Rep. 2019. https:\/\/doi.org\/10.1007\/s00592-020-01648-9.","journal-title":"Physiol Rep"},{"key":"380_CR71","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3389\/fphys.2020.00472","volume":"11","author":"P He","year":"2020","unstructured":"He P, Talukder MAH, Gao F. Oxidative stress and microvessel barrier dysfunction. Front Physiol. 2020;11:472.","journal-title":"Front Physiol"},{"key":"380_CR72","doi-asserted-by":"publisher","first-page":"708061","DOI":"10.3389\/fphys.2021.708061","volume":"12","author":"A Lloret","year":"2021","unstructured":"Lloret A, Esteve D, Lloret MA, Monllor P, Lopez B, Leon JL, et al. Is oxidative stress the link between cerebral small vessel disease, sleep disruption, and oligodendrocyte dysfunction in the onset of alzheimer\u2019s disease? Front Physiol. 2021;12:708061.","journal-title":"Front Physiol"},{"issue":"5","key":"380_CR73","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.bbadis.2016.06.015","volume":"1863","author":"SK Jha","year":"2017","unstructured":"Jha SK, Jha NK, Kumar D, Ambasta RK, Kumar P. Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration. Biochim Biophys Acta Mol Basis Dis. 2017;1863(5):1132\u201346.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"380_CR74","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fnins.2018.00196","volume":"12","author":"M Etchegoyen","year":"2018","unstructured":"Etchegoyen M, Nobile MH, Baez F, Posesorski B, Gonzalez J, Lago N, et al. Metabolic syndrome and Neuroprotection. Front Neurosci. 2018;12:196.","journal-title":"Front Neurosci"},{"key":"380_CR75","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00125-022-05730-5","volume":"65","author":"J Bailey","year":"2022","unstructured":"Bailey J, Coucha M, Bolduc DR, Burnett FN, Barrett AC, Ghaly M, et al. GLP-1 receptor nitration contributes to loss of brain pericyte function in a mouse model of diabetes. Diabetologia. 2022;65:1541\u201354. https:\/\/doi.org\/10.1007\/s00125-022-05730-5.","journal-title":"Diabetologia"},{"issue":"3","key":"380_CR76","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","volume":"482","author":"MM Gaschler","year":"2017","unstructured":"Gaschler MM, Stockwell BR. Lipid peroxidation in cell death. Biochem Biophys Res Commun. 2017;482(3):419\u201325.","journal-title":"Biochem Biophys Res Commun"},{"key":"380_CR77","doi-asserted-by":"publisher","first-page":"40753","DOI":"10.1038\/srep40753","volume":"7","author":"FU Amin","year":"2017","unstructured":"Amin FU, Shah SA, Kim MO. Vanillic acid attenuates Abeta1-42-induced oxidative stress and cognitive impairment in mice. Sci Rep. 2017;7:40753.","journal-title":"Sci Rep"},{"issue":"2","key":"380_CR78","doi-asserted-by":"publisher","first-page":"71","DOI":"10.31083\/j.fbl2702071","volume":"27","author":"Z Liu","year":"2022","unstructured":"Liu Z, Kumar M, Kabra A. Cucurbitacin B exerts neuroprotection in a murine Alzheimer\u2019s disease model by modulating oxidative stress, inflammation, and neurotransmitter levels. Front Biosci (Landmark Ed). 2022;27(2):71.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"380_CR79","doi-asserted-by":"publisher","first-page":"113767","DOI":"10.1016\/j.physbeh.2022.113767","volume":"249","author":"H Aggarwal","year":"2022","unstructured":"Aggarwal H, Gupta S, Sharma P, Sharma BM, Sharma B. Neurobehavioral and neurobiochemical effect of atomoxetine and N-acetylcysteine in streptozotocin diabetes induced endothelial dysfunction and related dementia. Physiol Behav. 2022;249:113767.","journal-title":"Physiol Behav"},{"key":"380_CR80","doi-asserted-by":"publisher","first-page":"360438","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala A, Munoz MF, Arguelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438.","journal-title":"Oxid Med Cell Longev"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00380-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-022-00380-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00380-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T06:05:06Z","timestamp":1668060306000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-022-00380-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["380"],"URL":"https:\/\/doi.org\/10.1186\/s12987-022-00380-6","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,7]]},"assertion":[{"value":"1 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies were approved by the Animal Care and Use Committee of the University of Cadiz in accordance with the guidelines for care and use of experimental animals (European Commission Directive 2010\/63\/UE and Spanish Royal Decree 53\/2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}